China Isotope & Radiation Corporation (HKG:1763)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
18.89
-0.02 (-0.11%)
Apr 29, 2026, 4:08 PM HKT
65.41%
Market Cap 6.05B
Revenue (ttm) 8.00B
Net Income (ttm) 364.36M
Shares Out 319.87M
EPS (ttm) 1.14
PE Ratio 16.60
Forward PE n/a
Dividend 0.35 (1.87%)
Ex-Dividend Date Jun 23, 2026
Volume 33,000
Average Volume 208,930
Open 19.22
Previous Close 18.91
Day's Range 18.52 - 19.22
52-Week Range 11.12 - 25.00
Beta 0.54
RSI 42.07
Earnings Date Aug 28, 2026

About China Isotope & Radiation

China Isotope & Radiation Corporation engages in the research and development, manufacture, and sale of nuclides, diagnostic, and therapeutic radiopharmaceuticals and radioactive source products for medical and industrial applications in China. It operates through five segments: Pharmaceuticals; Radioactive Source Products; Irradiation; Radiation Therapy Equipment and Related Services; and Other Businesses. The Pharmaceuticals segment engages in the research, development, manufacture, and sale of imaging diagnostic and therapeutic radiopharmace... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 1983
Employees 3,578
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 1763
Full Company Profile

Financial Performance

In 2025, China Isotope & Radiation's revenue was 7.19 billion, a decrease of -5.11% compared to the previous year's 7.57 billion. Earnings were 327.43 million, a decrease of -19.48%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.